Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
Pasqua MR, Tsoukas MA, Kobayati A, Aboznadah W, Jafar A, Haidar A
Key Companies in GLP-1 Analogues Market AstraZeneca Bristol-Myers Squibb Company D&D Pharmatech Eccogen Eli Lilly and Company Glenmark Pharmaceuticals Ltd
Castel1 on Behalf of the DC Cohort Executive Committee 1George Washington University Milken Institute School of Public Health, Washington, DC, United States, 2Kaiser Permanente Mid-Atlantic Permanente Medical Group, Washington, DC, United States
This dual action results in reduced appetite, slower digestion for prolonged satiety, and enhanced insulin sensitivity, which might also rev up your metabolism